Stock 6547 MEDIGEN VACCINE BIOLOGICS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

News Medigen Vaccine Biologics Corporation

Equities

6547

TW0006547003

End-of-day quote Taipei Exchange
Other stock markets
 06:00:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
52.5 TWD +4.37% Intraday chart for Medigen Vaccine Biologics Corporation +2.34% -25.11%
Mar. 15 Medigen Vaccine Biologics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Medigen Vaccine Biologics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Medigen Vaccine Biologics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Medigen Vaccine Biologics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
WHO Initiative Signs New Licensing Agreements On Covid-19 Technologies [press release]
AQ
Medigen Vaccine Biologics Corporation Provides License Covid-19 Vaccine to WHO C-TAP and UN Medicines Patent Pool
CI
Medigen Vaccine Biologics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Medigen Vaccine Biologics Corporation Withdraws Covid-19 Vaccine Provisional Application and Update with Three-Dose Data for Further Review
CI
Medigen Vaccine Biologics Corporation Approves the Election of Ming-Yi ,Wu as Independent Director and Member of Audit and Remuneration Committees
CI
Medigen Vaccine Biologics Corporation Files New Drug Application of MVC EV71 Vaccine to Drug Administration of Vietnam
CI
Medigen Vaccine Biologics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Medigen Vaccine Biologics Corporation Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Medigen Vaccine Biologics Corporation Announces Board Changes
CI
Medigen Vaccine Biologics Corporation Announces the Resignation of Chang, Ming-Cheng as Independent Director
CI
Medigen Vaccine Biologics Corporation Receives the NDA Approval Letter of Mvcquadrivalent Influenza Vaccine from Taiwan Food and Drug Administration
CI
Medigen Vaccine Biologics Corporation Announces Results of MVC COVID-19 Vaccine Phase 3 Clinical Trial in Thailand
CI
Medigen Vaccine Biologics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Taiwan firm to provide free COVID-19 testing for Japan-bound visitors
AQ
Medigen Vaccine Biologics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Medigen Vaccine Biologics : Clarification on media reports
PU
Medigen Vaccine Biologics : Announcement of the company's resolutions on the stock dividend ex-rights base date
PU
Medigen Vaccine Biologics : Announcement of the Company's full receipt of cash capital increase in 2022 and the reference date of capital increase
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 6547 Stock
  4. News Medigen Vaccine Biologics Corporation